Featured Research

from universities, journals, and other organizations

New Procedure Makes Kidney Transplant An Option For Thousands On Waiting List

Date:
February 13, 2001
Source:
Mayo Clinic
Summary:
A team of Mayo Clinic kidney transplant specialists has developed a new kidney transplant procedure that could make transplants possible for thousands of people who previously were unlikely to have a successful transplant. The advancement, called positive crossmatch transplants, greatly reduces the chance of organ rejection in patients with elevated antibody levels.

Rochester, MN -- A team of Mayo Clinic kidney transplant specialists has developed a new kidney transplant procedure that could make transplants possible for thousands of people who previously were unlikely to have a successful transplant.

Related Articles


The advancement, called positive crossmatch transplants, greatly reduces the chance of organ rejection in patients with elevated antibody levels. Previously, these elevated antibody levels made tissue rejection almost certain.

Mayo Clinic is one of three medical centers in the United States that offer this procedure.

About 45,000 people are waiting for a cadaver kidney in the United States; about 8,000 kidneys are available every year.

About 7,000 of those waiting are affected by this elevated antibody level. "The only option available for these people was to stay on dialysis," says Mark Stegall, M.D., a Mayo Clinic kidney and pancreas transplantation surgeon. "It was very unlikely they would ever get a transplant."

Dialysis works like an artificial kidney. It prolongs life but it is not ideal. Three times a week for four hours at a stretch, patients hook up to a machine that removes waste fluids and regulates the body’s chemical and blood balances.

Physicians aren’t certain what causes patients to have elevated antibody levels that make traditional transplants likely to fail. Many of those with elevated antibody levels have had a previous failed kidney transplant. Others have had multiple pregnancies or multiple blood transfusions. Many are young or middle-aged adults who are otherwise healthy.

Improved results by removing antibodies

Prior to a positive crossmatch transplant, patients undergo a dialysis-like process called plasmapheresis, where the antibodies that cause tissue rejection are removed. The risk of rejection is also reduced by new medicines that specifically target cells that make the antibodies and removing the patient’s spleen which is responsible for antibody production.

The positive crossmatch process is similar to the process used for ABO-incompatible living-donor kidney transplants -- another recent advancement in transplants -- where patients can receive kidneys from living donors with blood types different from their own.

"With positive crossmatch transplants, we are taking it a step further, making it possible for the patients to accept different tissue types in addition to different blood types," says Dr. Stegall.

So far, Mayo Clinic surgeons have performed 20 ABO-incompatible kidney transplants and four positive crossmatch kidney transplants.

"The results and recovery time for both positive crossmatch and ABO-incompatible transplants are similar to other living-donor kidney transplants," says Dr. Stegall. "That’s remarkable, especially for the positive crossmatch patients. Before this, they didn’t have the option of a transplant."

Living donors are used for both ABO-incompatible and positive crossmatch transplants. About 150 of the 200 kidney transplants performed this year at Mayo Clinic will use living donors.

Using living donors offers many benefits: a shorter waiting time for transplants; kidneys can be tested prior to transplant; they routinely function immediately while cadaver kidneys may take several weeks to work; and they typically last much longer than kidneys from cadavers.

Positive crossmatch kidney transplants move medical science one step closer to xenotransplantation (pig-to-human organ transplants). "The barrier to putting a pig kidney into a human is the presence of antibodies," says Dr. Stegall. "With positive crossmatch transplants, we have crossed that antibody barrier in a human-to-human transplant."

"We hope to take what we’ve learned here to move closer to xenotransplantation, a transplant option that we hope will alleviate years of waiting for donor organs," says Dr. Stegall.


Story Source:

The above story is based on materials provided by Mayo Clinic. Note: Materials may be edited for content and length.


Cite This Page:

Mayo Clinic. "New Procedure Makes Kidney Transplant An Option For Thousands On Waiting List." ScienceDaily. ScienceDaily, 13 February 2001. <www.sciencedaily.com/releases/2001/02/010212074323.htm>.
Mayo Clinic. (2001, February 13). New Procedure Makes Kidney Transplant An Option For Thousands On Waiting List. ScienceDaily. Retrieved November 28, 2014 from www.sciencedaily.com/releases/2001/02/010212074323.htm
Mayo Clinic. "New Procedure Makes Kidney Transplant An Option For Thousands On Waiting List." ScienceDaily. www.sciencedaily.com/releases/2001/02/010212074323.htm (accessed November 28, 2014).

Share This


More From ScienceDaily



More Health & Medicine News

Friday, November 28, 2014

Featured Research

from universities, journals, and other organizations


Featured Videos

from AP, Reuters, AFP, and other news services

Rural India's Low-Cost Sanitary Pad Revolution

Rural India's Low-Cost Sanitary Pad Revolution

AFP (Nov. 28, 2014) — One man hopes his invention -– a machine that produces cheap sanitary pads –- will help empower Indian women. Duration: 01:51 Video provided by AFP
Powered by NewsLook.com
Research on Bats Could Help Develop Drugs Against Ebola

Research on Bats Could Help Develop Drugs Against Ebola

AFP (Nov. 28, 2014) — In Africa's only biosafety level 4 laboratory, scientists have been carrying out experiments on bats to understand how virus like Ebola are being transmitted, and how some of them resist to it. Duration: 01:18 Video provided by AFP
Powered by NewsLook.com
Ebola Leaves Orphans Alone in Sierra Leone

Ebola Leaves Orphans Alone in Sierra Leone

AFP (Nov. 27, 2014) — The Ebola epidemic sweeping Sierra Leone is having a profound effect on the country's children, many of whom have been left without any family members to support them. Duration: 01:02 Video provided by AFP
Powered by NewsLook.com
Experimental Ebola Vaccine Shows Promise In Human Trial

Experimental Ebola Vaccine Shows Promise In Human Trial

Newsy (Nov. 27, 2014) — A recent test of a prototype Ebola vaccine generated an immune response to the disease in subjects. Video provided by Newsy
Powered by NewsLook.com

Search ScienceDaily

Number of stories in archives: 140,361

Find with keyword(s):
 
Enter a keyword or phrase to search ScienceDaily for related topics and research stories.

Save/Print:
Share:  

Breaking News:

Strange & Offbeat Stories

 

Health & Medicine

Mind & Brain

Living & Well

In Other News

... from NewsDaily.com

Science News

Health News

Environment News

Technology News



Save/Print:
Share:  

Free Subscriptions


Get the latest science news with ScienceDaily's free email newsletters, updated daily and weekly. Or view hourly updated newsfeeds in your RSS reader:

Get Social & Mobile


Keep up to date with the latest news from ScienceDaily via social networks and mobile apps:

Have Feedback?


Tell us what you think of ScienceDaily -- we welcome both positive and negative comments. Have any problems using the site? Questions?
Mobile iPhone Android Web
Follow Facebook Twitter Google+
Subscribe RSS Feeds Email Newsletters
Latest Headlines Health & Medicine Mind & Brain Space & Time Matter & Energy Computers & Math Plants & Animals Earth & Climate Fossils & Ruins